Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueReturn on AssetsReturn on Sales

Mainz Biomed (MYNZ) Gross Margin (2022 - 2023)

Historic Gross Margin for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to 62.74%.

  • Mainz Biomed's Gross Margin rose 439600.0% to 62.74% in Q4 2023 from the same period last year, while for Dec 2023 it was 56.91%, marking a year-over-year increase of 225400.0%. This contributed to the annual value of 64.31% for FY2024, which is 73900.0% up from last year.
  • According to the latest figures from Q4 2023, Mainz Biomed's Gross Margin is 62.74%, which was up 439600.0% from 47.99% recorded in Q3 2023.
  • Mainz Biomed's Gross Margin's 5-year high stood at 62.74% during Q4 2023, with a 5-year trough of 18.78% in Q4 2022.